Notice Number: NOT-HL-19-692
Key Dates
Release Date: April 11, 2019
RFA-HL-20-003: Disparities Elimination through Coordinated Interventions to Prevent and Control Heart and Lung Disease Risk (DECIPHeR) (UG3/UH3 Clinical Trial Optional)
RFA-HL-20-004: Disparities Elimination through Coordinated Interventions to Prevent and Control Heart and Lung Disease Risk (DECIPHeR) - Research Coordinating Center (RCC) (U24 Clinical Trial Not Allowed)
Issued by
National Heart, Lung, and Blood Institute (NHLBI)
Purpose
On March 11, 2019, NHLBI issued the Funding Opportunity Announcement (FOA) RFA-HL-20-003, Disparities Elimination through Coordinated Interventions to Prevent and Control Heart and Lung Disease Risk (DECIPHeR) (UG3/UH3 Clinical Trial Optional).
A pre-submission technical assistance webinar for RFA-HL-20-003 is scheduled for Monday, April 15, 2019 at 1:00 p.m. EST. The webinar will include a review of the purpose and objectives of this FOA, application and peer review requirements, and budget considerations.
All prospective applicants are invited to attend and are strongly encouraged to send relevant questions prior to the webinar in order to maximize the use of time. Specific questions should be sent via email to [email protected] at least 24 hours prior to the webinar.
Session date and time: Monday, April 15, 2019, 1:00-2:00 pm EST
Join Webex Meeting
Event password: decipher
Number (US/Canada): 1-650-479-3208
Meeting Number/Access code: 625 433 626
Event address for attendees: https://nih.webex.com/nih/onstage/g.php?MTID=ee9da6721b8b5ed688082ed645c150be4
Participation in this webinar, although encouraged, is optional and is not required for the submission of an application in response to RFA-HL-20-003.
This Notice also provides information regarding the availability of Frequently Asked Questions (FAQs) to address common questions from potential applicants regarding RFA-HL-20-003, which are available at: https://www.nhlbi.nih.gov/grants-and-training/funding-opportunities-and-contacts/all-funding-opportunity-announcements-2907.
All applicants are encouraged to review the FAQs prior to submitting an application. The FAQs may be updated, as needed. Applicants are encouraged to frequently check for updates to the FAQs regularly until the submission date.
Inquiries
Please direct all inquiries to:
Melissa C. Green Parker, Ph.D.
Center for Translation Research and Implementation Science (CTRIS)
Telephone: 301-827-4893
Email: [email protected]